VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASH 2020 | Latest updates in myeloma: key takeaways from ASH 2020

Daniel AuClair, PhD, Multiple Myeloma Research Foundation, Norwalk, CT, discusses recent advances in multiple myeloma research that were presented at ASH 2020. These include progression in the bispecific antibody field, with new targets beyond BCMA being investigated. For example, data on GPRC5D-directed bispecifics was shown, as well as novel combinations of immune and targeted therapies. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter